Comprehensive in vitro Proarrhythmia Assay (CiPA): Pending issues for successful validation and implementation

Download

Cavero I, Guillon JM, Ballet V, Clements M, Gerbeau JF, Holzgrefe H.

J Pharmacol Toxicol Methods, 2016

Related Resources
Comprehensive in vitro cardiac safety assessment using human stem cell technology: Overview of CSAHi HEART initiative
Comprehensive Translational Assessment of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias
Bridging Functional and Structural Cardiotoxicity Assays Using Human Embryonic Stem Cell-Derived Cardiomyocytes for a More Comprehensive Risk Assessment

Related Products

System

Maestro Pro

High-throughput MEA and live-cell analysis system

Learn more >>
Axion BioSystems Maestro Pro MEA system
System

Maestro Edge

MEA and live-cell analysis system

Learn more >>
Axion BioSystems Maestro Edge system for MEA assays
Software

Cardiac Module

Record the four key measures of cardiac performance: action potential, field potential, propagation, and contractility

Learn more >>
Axion BioSystems Cardiac software Module for MEA experiments